Fgf15 Mouse (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of FGF15 mRNA CTD PMID:22178739 Fgf15 Mouse (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 NR1H4 protein affects the reaction [epigallocatechin gallate results in increased expression of FGF15 mRNA] CTD PMID:22178739 Fgf15 Mouse (S)-amphetamine increases expression EXP 6480464 Dextroamphetamine results in increased expression of FGF15 mRNA CTD PMID:12205029 Fgf15 Mouse (S)-amphetamine multiple interactions EXP 6480464 SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of FGF15 mRNA] CTD PMID:12205029 Fgf15 Mouse 1-naphthyl isothiocyanate multiple interactions EXP 6480464 alisol B 23-acetate promotes the reaction [1-Naphthylisothiocyanate results in increased expression of FGF15 mRNA] CTD PMID:25655198 Fgf15 Mouse 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FGF15 mRNA CTD PMID:25655198 Fgf15 Mouse 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FGF15 mRNA CTD PMID:34058177 Fgf15 Mouse 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FGF15 mRNA CTD PMID:26040663 Fgf15 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of FGF15 mRNA; alisol B 23-acetate more ... CTD PMID:26040663|PMID:34058177 Fgf15 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FGF15 mRNA CTD PMID:19465110 Fgf15 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [AHR gene mutant form affects the susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of more ... CTD PMID:29452137 Fgf15 Mouse 2,3,7,8-Tetrachlorodibenzofuran multiple interactions EXP 6480464 AHR protein promotes the reaction [2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FGF15 mRNA] CTD PMID:25768209 Fgf15 Mouse 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FGF15 mRNA CTD PMID:25768209 Fgf15 Mouse aflatoxin B1 multiple interactions EXP 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in decreased expression of FGF15 mRNA]; fexaramine inhibits more ... CTD PMID:37030333 Fgf15 Mouse aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of FGF15 mRNA CTD PMID:37030333 Fgf15 Mouse aflatoxin B1 decreases secretion EXP 6480464 Aflatoxin B1 results in decreased secretion of FGF15 protein CTD PMID:37030333 Fgf15 Mouse aflatoxin B1 increases methylation ISO FGF19 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of FGF19 gene CTD PMID:27153756 Fgf15 Mouse all-trans-retinoic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Tretinoin results in increased expression of FGF19 mRNA CTD PMID:21274875 Fgf15 Mouse all-trans-retinoic acid multiple interactions ISO FGF19 (Homo sapiens) 6480464 Ursodeoxycholic Acid promotes the reaction [Tretinoin results in increased expression of FGF19 mRNA] CTD PMID:21274875 Fgf15 Mouse ammonium chloride affects expression ISO Fgf19 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of FGF15 mRNA CTD PMID:16483693 Fgf15 Mouse anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO FGF19 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [FGF19 protein results in decreased expression of CYP17A1 mRNA]; pyrazolanthrone inhibits more ... CTD PMID:16269825 Fgf15 Mouse arsane affects expression ISO FGF19 (Homo sapiens) 6480464 Arsenic affects the expression of FGF19 protein CTD PMID:24675094 Fgf15 Mouse arsenic atom affects expression ISO FGF19 (Homo sapiens) 6480464 Arsenic affects the expression of FGF19 protein CTD PMID:24675094 Fgf15 Mouse atorvastatin calcium decreases expression EXP 6480464 Atorvastatin results in decreased expression of FGF15 mRNA CTD PMID:25278499 Fgf15 Mouse Augmentin increases expression ISO FGF19 (Homo sapiens) 6480464 Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA CTD PMID:34767876 Fgf15 Mouse benzo[a]pyrene increases methylation ISO FGF19 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FGF19 promoter CTD PMID:27901495 Fgf15 Mouse beta-hexachlorocyclohexane decreases expression EXP 6480464 beta-hexachlorocyclohexane results in decreased expression of FGF15 mRNA CTD PMID:28392238 Fgf15 Mouse bilirubin IXalpha increases abundance EXP 6480464 FGF15 gene mutant form results in increased abundance of Bilirubin CTD PMID:24699334 Fgf15 Mouse bis(2-ethylhexyl) phthalate multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FGF15 more ... CTD PMID:23359474 Fgf15 Mouse bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of FGF15 mRNA CTD PMID:34319233 Fgf15 Mouse bis(2-ethylhexyl) phthalate decreases expression ISO FGF19 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of FGF19 mRNA CTD PMID:31163220 Fgf15 Mouse bisphenol A multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FGF15 more ... CTD PMID:23359474 Fgf15 Mouse bisphenol A increases methylation ISO FGF19 (Homo sapiens) 6480464 bisphenol A results in increased methylation of FGF19 promoter CTD PMID:27271280 Fgf15 Mouse bisphenol A decreases expression ISO Fgf19 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FGF19 mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016 Fgf15 Mouse cadmium dichloride increases expression ISO FGF19 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of FGF19 mRNA CTD PMID:38568856 Fgf15 Mouse cefalotin multiple interactions EXP 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA CTD PMID:24657338 Fgf15 Mouse chenodeoxycholic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Chenodeoxycholic Acid results in increased expression of FGF19 mRNA CTD PMID:16269825|PMID:17696253|PMID:25055961|PMID:27174168 Fgf15 Mouse chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of FGF15 mRNA CTD PMID:25582706 Fgf15 Mouse chenodeoxycholic acid increases expression ISO Fgf19 (Rattus norvegicus) 6480464 Chenodeoxycholic Acid results in increased expression of FGF15 mRNA; Chenodeoxycholic Acid results in increased expression more ... CTD PMID:20835427|PMID:29222744 Fgf15 Mouse chenodeoxycholic acid multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 [Chenodeoxycholic Acid results in increased expression of FGF19 protein] which results in decreased expression of more ... CTD PMID:20835427 Fgf15 Mouse chenodeoxycholic acid multiple interactions ISO FGF19 (Homo sapiens) 6480464 [[Chenodeoxycholic Acid results in increased activity of NR1H4 protein] which binds to FGF19 promoter] which more ... CTD PMID:22561792 Fgf15 Mouse cholesterol multiple interactions ISO FGF19 (Homo sapiens) 6480464 [FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of more ... CTD PMID:30996006 Fgf15 Mouse cholic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Cholic Acid results in increased expression of FGF19 mRNA CTD PMID:25055961 Fgf15 Mouse cholic acid increases expression EXP 6480464 Cholic Acid results in increased expression of FGF15 mRNA CTD PMID:25582706 Fgf15 Mouse cholic acid multiple interactions ISO FGF19 (Homo sapiens) 6480464 [[Cholic Acid results in increased activity of NR1H4 protein] which binds to FGF19 promoter] which more ... CTD PMID:22561792 Fgf15 Mouse ciprofloxacin decreases expression EXP 6480464 Ciprofloxacin results in decreased expression of FGF15 mRNA CTD PMID:24657338 Fgf15 Mouse clavulanic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Clavulanic Acid results in increased expression of FGF19 mRNA CTD PMID:34767876 Fgf15 Mouse clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of FGF15 mRNA CTD PMID:28973556 Fgf15 Mouse clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of FGF15 mRNA CTD PMID:29175453 Fgf15 Mouse DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of FGF15 mRNA CTD PMID:28392238 Fgf15 Mouse deoxycholic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Deoxycholic Acid results in increased expression of FGF19; Deoxycholic Acid results in increased expression of more ... CTD PMID:22268002|PMID:25055961 Fgf15 Mouse deoxycholic acid increases expression EXP 6480464 Deoxycholic Acid results in increased expression of FGF15 mRNA CTD PMID:25582706 Fgf15 Mouse deoxycholic acid multiple interactions ISO FGF19 (Homo sapiens) 6480464 [[Deoxycholic Acid results in increased activity of NR1H4 protein] which binds to FGF19 promoter] which more ... CTD PMID:22561792 Fgf15 Mouse dexamethasone decreases expression ISO Fgf19 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of FGF15 mRNA CTD PMID:29222744 Fgf15 Mouse dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with Ibuprofen] results in decreased expression of FGF15 mRNA; [Dexamethasone co-treated with Ibuprofen] more ... CTD PMID:29222744 Fgf15 Mouse dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of FGF15 mRNA; Dexamethasone results in decreased expression of FGF15 more ... CTD PMID:29222744 Fgf15 Mouse dexamethasone multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 [Ibuprofen co-treated with Dexamethasone] results in decreased expression of FGF15 mRNA CTD PMID:29222744 Fgf15 Mouse dextran sulfate multiple interactions EXP 6480464 Dextran Sulfate results in increased expression of and results in increased secretion of FGF15 protein CTD PMID:27580383 Fgf15 Mouse diazinon affects expression ISO Fgf19 (Rattus norvegicus) 6480464 Diazinon affects the expression of FGF15 mRNA CTD PMID:19130878 Fgf15 Mouse dibutyl phthalate multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FGF15 more ... CTD PMID:23359474 Fgf15 Mouse diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of FGF15 mRNA CTD PMID:38815664 Fgf15 Mouse dieldrin affects expression ISO Fgf19 (Rattus norvegicus) 6480464 Dieldrin affects the expression of FGF15 mRNA CTD PMID:19130878 Fgf15 Mouse dihydroartemisinin multiple interactions ISO Fgf19 (Rattus norvegicus) 15036816 Dihydroartemisinin inhibits the reaction [ethanol decreases expression of FGF19 protein in liver and intestine] RGD Fgf15 Mouse diosgenin multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FGF19 mRNA] CTD PMID:33383043 Fgf15 Mouse dorsomorphin multiple interactions ISO FGF19 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Fgf15 Mouse enilconazole decreases expression EXP 6480464 enilconazole results in decreased expression of FGF15 mRNA CTD PMID:29451352 Fgf15 Mouse enilconazole increases expression EXP 6480464 enilconazole results in increased expression of FGF15 mRNA CTD PMID:32814239 Fgf15 Mouse entinostat increases expression ISO FGF19 (Homo sapiens) 6480464 entinostat results in increased expression of FGF19 mRNA CTD PMID:26272509 Fgf15 Mouse entinostat multiple interactions ISO FGF19 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Fgf15 Mouse ethanol decreases expression ISO Fgf19 (Rattus norvegicus) 15036816 ethanol decreases expression of FGF19 protein in liver and intestine RGD Fgf15 Mouse ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of FGF15 mRNA CTD PMID:34492310 Fgf15 Mouse Fexaramine multiple interactions EXP 6480464 fexaramine inhibits the reaction [Aflatoxin B1 results in decreased expression of FGF15 mRNA]; fexaramine inhibits more ... CTD PMID:37030333 Fgf15 Mouse furan increases expression ISO Fgf19 (Rattus norvegicus) 6480464 furan results in increased expression of FGF19 mRNA CTD PMID:38160780 Fgf15 Mouse furan multiple interactions EXP 6480464 [furan co-treated with rhodioloside] results in increased expression of FGF15 mRNA CTD PMID:32251705 Fgf15 Mouse gentamycin increases expression ISO Fgf19 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of FGF19 mRNA CTD PMID:33387578 Fgf15 Mouse guggulsterone multiple interactions ISO Fgf19 (Rattus norvegicus) 15036816 Z-guggulsterone reverses the reaction [Dihydroartemisinin inhibits the reaction [ethanol decreases expression of FGF19 protein in more ... RGD Fgf15 Mouse GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of FGF15 mRNA; GW 4064 results in increased expression more ... CTD PMID:22918042|PMID:22961653|PMID:27609522|PMID:36511616 Fgf15 Mouse GW 4064 increases expression ISO FGF19 (Homo sapiens) 6480464 GW 4064 results in increased expression of FGF19 mRNA CTD PMID:16269825 Fgf15 Mouse GW 4064 multiple interactions ISO FGF19 (Homo sapiens) 6480464 [[GW 4064 results in increased activity of NR1H4 protein] which binds to FGF19 promoter] which more ... CTD PMID:22561792 Fgf15 Mouse GW 4064 multiple interactions EXP 6480464 [GW 4064 co-treated with Dietary Fats] results in decreased expression of FGF15 mRNA; epiallopregnanolone sulfate more ... CTD PMID:20091679|PMID:22918042|PMID:22961653|PMID:28223344|PMID:30996006|PMID:36511616 Fgf15 Mouse heparin affects binding ISO FGF19 (Homo sapiens) 6480464 Heparin binds to FGF19 protein CTD PMID:14730967 Fgf15 Mouse heparin multiple interactions ISO FGF19 (Homo sapiens) 6480464 Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein] CTD PMID:10525310 Fgf15 Mouse ibuprofen multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 [Ibuprofen co-treated with Dexamethasone] results in decreased expression of FGF15 mRNA CTD PMID:29222744 Fgf15 Mouse ibuprofen multiple interactions EXP 6480464 [Dexamethasone co-treated with Ibuprofen] results in decreased expression of FGF15 mRNA; [Dexamethasone co-treated with Ibuprofen] more ... CTD PMID:29222744 Fgf15 Mouse ibuprofen decreases expression EXP 6480464 Ibuprofen results in decreased expression of FGF15 mRNA; Ibuprofen results in decreased expression of FGF15 more ... CTD PMID:29222744|PMID:38815664 Fgf15 Mouse indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of FGF15 mRNA CTD PMID:38815664 Fgf15 Mouse lithocholic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Lithocholic Acid results in increased expression of FGF19 mRNA CTD PMID:17696253|PMID:25055961 Fgf15 Mouse lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of FGF15 mRNA CTD PMID:25582706 Fgf15 Mouse lithocholic acid multiple interactions ISO FGF19 (Homo sapiens) 6480464 [Lithocholic Acid results in increased activity of NR1H4 protein] which results in increased expression of more ... CTD PMID:17696253|PMID:22561792 Fgf15 Mouse metformin multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of FGF15 mRNA CTD PMID:34058177 Fgf15 Mouse methotrexate decreases expression ISO FGF19 (Homo sapiens) 6480464 Methotrexate results in decreased expression of FGF19 mRNA CTD PMID:17400583 Fgf15 Mouse N-methyl-4-phenylpyridinium increases expression ISO FGF19 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FGF19 mRNA CTD PMID:24810058 Fgf15 Mouse neomycin multiple interactions EXP 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA CTD PMID:24657338 Fgf15 Mouse nickel atom affects expression ISO Fgf19 (Rattus norvegicus) 6480464 Nickel affects the expression of FGF15 mRNA CTD PMID:19130878 Fgf15 Mouse niclosamide increases expression ISO FGF19 (Homo sapiens) 6480464 Niclosamide results in increased expression of FGF19 mRNA CTD PMID:36318118 Fgf15 Mouse obeticholic acid multiple interactions ISO Fgf19 (Rattus norvegicus) 15036816 Obeticholic acid inhibits the reaction [ethanol decreases expression of FGF19 protein in liver and intestine] RGD Fgf15 Mouse obeticholic acid increases expression ISO FGF19 (Homo sapiens) 6480464 obeticholic acid results in increased expression of FGF19 mRNA CTD PMID:27939613 Fgf15 Mouse obeticholic acid increases secretion ISO FGF19 (Homo sapiens) 6480464 obeticholic acid results in increased secretion of FGF19 protein CTD PMID:27939613 Fgf15 Mouse obeticholic acid multiple interactions EXP 6480464 NR1H4 gene mutant form inhibits the reaction [obeticholic acid results in increased expression of FGF15 more ... CTD PMID:22918042 Fgf15 Mouse obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of FGF15 mRNA CTD PMID:22918042 Fgf15 Mouse panobinostat increases expression ISO FGF19 (Homo sapiens) 6480464 panobinostat results in increased expression of FGF19 mRNA CTD PMID:26272509 Fgf15 Mouse panobinostat multiple interactions ISO FGF19 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Fgf15 Mouse paracetamol decreases expression ISO Fgf19 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of FGF19 mRNA CTD PMID:33387578 Fgf15 Mouse phenethyl caffeate multiple interactions EXP 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of FGF15 mRNA; more ... CTD PMID:28223344 Fgf15 Mouse phosphatidylcholine decreases abundance EXP 6480464 FGF19 protein results in decreased abundance of Phosphatidylcholines CTD PMID:29416063 Fgf15 Mouse phosphatidylethanolamine increases abundance EXP 6480464 FGF19 protein results in increased abundance of phosphatidylethanolamine CTD PMID:29416063 Fgf15 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FGF15 mRNA CTD PMID:17426115 Fgf15 Mouse procymidone affects expression EXP 6480464 procymidone affects the expression of FGF15 mRNA CTD PMID:36764477 Fgf15 Mouse prothioconazole decreases expression EXP 6480464 prothioconazole results in decreased expression of FGF15 mRNA CTD PMID:36007749 Fgf15 Mouse Prothioconazole-desthio decreases expression EXP 6480464 prothioconazole-desthio results in decreased expression of FGF15 mRNA CTD PMID:36007749 Fgf15 Mouse rifampicin multiple interactions ISO FGF19 (Homo sapiens) 6480464 [Rifampin binds to and results in increased activity of NR1I2 protein] which results in increased more ... CTD PMID:17696253 Fgf15 Mouse rifampicin increases expression ISO FGF19 (Homo sapiens) 6480464 Rifampin results in increased expression of FGF19 mRNA CTD PMID:17696253 Fgf15 Mouse ritonavir increases expression ISO FGF19 (Homo sapiens) 6480464 Ritonavir results in increased expression of FGF19 mRNA CTD PMID:26626330 Fgf15 Mouse rotenone increases expression ISO FGF19 (Homo sapiens) 6480464 Rotenone results in increased expression of FGF19 mRNA CTD PMID:29955902 Fgf15 Mouse S-adenosyl-L-homocysteine decreases abundance EXP 6480464 FGF19 protein results in decreased abundance of S-Adenosylhomocysteine CTD PMID:29416063 Fgf15 Mouse S-adenosyl-L-methioninate increases abundance EXP 6480464 FGF19 protein results in increased abundance of S-Adenosylmethionine CTD PMID:29416063 Fgf15 Mouse S-adenosyl-L-methionine increases abundance EXP 6480464 FGF19 protein results in increased abundance of S-Adenosylmethionine CTD PMID:29416063 Fgf15 Mouse Salidroside multiple interactions EXP 6480464 [furan co-treated with rhodioloside] results in increased expression of FGF15 mRNA CTD PMID:32251705 Fgf15 Mouse SB 431542 multiple interactions ISO FGF19 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Fgf15 Mouse silver atom increases expression EXP 6480464 Silver results in increased expression of FGF15 mRNA CTD PMID:27131904 Fgf15 Mouse silver(0) increases expression EXP 6480464 Silver results in increased expression of FGF15 mRNA CTD PMID:27131904 Fgf15 Mouse simvastatin multiple interactions ISO Fgf19 (Rattus norvegicus) 6480464 Simvastatin inhibits the reaction [Dietary Fats results in increased expression of FGF19 mRNA] CTD PMID:33383043 Fgf15 Mouse sodium arsenite increases expression ISO FGF19 (Homo sapiens) 6480464 sodium arsenite results in increased expression of FGF19 mRNA CTD PMID:25879800|PMID:38568856 Fgf15 Mouse sodium arsenite decreases expression ISO FGF19 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of FGF19 mRNA CTD PMID:34032870 Fgf15 Mouse sotorasib multiple interactions ISO FGF19 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FGF19 mRNA CTD PMID:36139627 Fgf15 Mouse streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of FGF15 mRNA; [Dietary Fats co-treated more ... CTD PMID:29382564 Fgf15 Mouse taurocholic acid multiple interactions EXP 6480464 [Taurocholic Acid binds to and results in increased activity of NR1H4 protein] which results in more ... CTD PMID:16284190 Fgf15 Mouse taurocholic acid increases expression EXP 6480464 Taurocholic Acid results in increased expression of FGF15 mRNA CTD PMID:16284190 Fgf15 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of FGF15 promoter CTD PMID:35295148 Fgf15 Mouse titanium dioxide increases methylation EXP 6480464 titanium dioxide results in increased methylation of FGF15 gene CTD PMID:35295148 Fgf15 Mouse trametinib multiple interactions ISO FGF19 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FGF19 mRNA CTD PMID:36139627 Fgf15 Mouse triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of FGF15 mRNA CTD PMID:36563926 Fgf15 Mouse triptonide increases expression EXP 6480464 triptonide results in increased expression of FGF15 mRNA CTD PMID:33045310 Fgf15 Mouse ursodeoxycholic acid increases expression ISO FGF19 (Homo sapiens) 6480464 Ursodeoxycholic Acid results in increased expression of FGF19 mRNA CTD PMID:25055961 Fgf15 Mouse ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of FGF15 mRNA CTD PMID:25582706 Fgf15 Mouse ursodeoxycholic acid multiple interactions ISO FGF19 (Homo sapiens) 6480464 Ursodeoxycholic Acid promotes the reaction [Tretinoin results in increased expression of FGF19 mRNA] CTD PMID:21274875 Fgf15 Mouse valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FGF15 mRNA CTD PMID:19136453|PMID:20546886|PMID:21427059 Fgf15 Mouse valproic acid affects expression ISO FGF19 (Homo sapiens) 6480464 Valproic Acid affects the expression of FGF19 mRNA CTD PMID:25979313